Abstract
Intra-aortic balloon pump (IABP) is an assist device commonly used in severe cardiac failure and to preoperatively support treatment of high-risk patients by improving myocardial perfusion and lowering cardiac afterload. Although its benefits for improving cardiac function have been well documented, the effects of IABP on the cerebral circulation are still not well understood. However, it has been demonstrated that the use of IABP can change the temporal pattern of cerebral blood flow waveforms during the cardiac cycle, leading to characteristic double-peaked waveforms with the occurrence of transient reversed, negative diastolic flow in some cases. Nevertheless, more information is needed about the impacts of IABP on the cerebral hemodynamic and the neurological consequences of its use. This chapter describes the use of transcranial Doppler ultrasound (TCD), a relatively inexpensive and noninvasive tool, in patients with an IABP. TCD has considerable potential for real-time bedside monitoring of these patients, allowing observation of the effects of IABP on cerebral hemodynamics and cerebral autoregulation (CA). Of considerable value is TCD/TCCS potential to detect and prevent neurological complications in this group of patients.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Intra-aortic balloon
- IABP
- Cerebral hemodynamics
- Cerebral autoregulation
- Transient
- TCD
- Reversal of diastolic flow
-
1.
Intra-aortic balloon pump (IABP) modifies the pattern of arterial blood pressure pulsatility leading to concurrent changes in the cerebral blood flow (CBF) waveform during the cardiac cycle.
-
2.
Transcranial Doppler ultrasound (TCD/TCCS) allows measurement of CBF velocity (CBFV) in the middle cerebral artery, or other large intracranial arteries, with considerable potential to identify cerebral hemodynamic disturbances in critically ill patients.
-
3.
TCD can detect reversal of diastolic CBFV which is likely to be iatrogenic and should be minimized.
-
4.
Microemboli produced by IABP should be evaluated with TCD to avoid neurological complications.
-
5.
Patients suspected of clinical brain death need IABP to be on standby to allow a proper determination of the actual CBFV by TCD/TCCS.
1 Introduction
Intra-aortic balloon pump (IABP) remains the most widely used form of mechanical circulatory support in current clinical practice [1]. The accepted clinical indications for IABP use are wide ranging, but the available clinical evidence is largely limited to cardiogenic shock, myocardial infarction without shock, high-risk percutaneous coronary intervention, and perioperative of cardiac surgery [1]. In neurological critical care patients, IABP has been used in subarachnoid hemorrhage (SAH) [2,3,4].
The physiological premise underlying the utilization of IABP was first described by Kantrowitz in animal models in 1953, based on the diastolic augmentation of aortic root and coronary pressure [5]. Percutaneous IABP was first applied clinically in 1980 and remains the most widely used form of left ventricular mechanical support in most centers [6].
The IABP is a flexible balloon catheter with two lumens—one to allow flushing, aspiration, and for aortic pressure to be transduced; the other to allow inflation/deflation with the rapid shuttling of gas (usually helium) to and from the balloon [7]. Triggering of the insufflation and deflation is synchronized by the trace of the electrocardiogram (ECG) or the systemic arterial blood pressure (ABP) [8]. Of considerable relevance, the control of triggering can be changed to change the time delay when inflation takes place after the QRS complex of the ECG, leading to changes in the temporal pattern of the ABP waveform as it will be discussed later.
In this procedure, a balloon is placed into the aorta just distal to the left subclavian artery, generally via the femoral artery [6]. The balloon is connected to an external pump through a catheter. The pumping is timed so that the balloon inflates immediately after the aortic valve closes. Balloon inflation decreases diastolic aortic runoff and increases diastolic aortic pressure; these changes increase perfusion of the coronary arteries. The balloon deflates just before systole. Balloon deflation results in systolic unloading and a decrease in the aortic impedance to left ventricular ejection [1, 9] (Fig. 61.1). This combination causes relatively little change in the mean aortic pressure but decreases the left ventricular pressure by approximately 20% and increases coronary perfusion and cardiac output by up to 40%. As a consequence of these hemodynamic changes, cardiac workload and myocardial oxygen consumption are reduced in patients with a failing heart in cardiogenic shock or heart failure [10, 11].
IABP use is not free from complications. Postmortem examinations have shown multiple etiologies, including cerebral air embolism secondary to IABP rupture, compromised spinal cord blood supply due to mechanical trauma, dissecting hematoma of the thoracic aorta , spinal cord necrosis , microatheroembolism to radicular arteries, and other minor cerebrovascular events [12,13,14,15].
Given ongoing concerns about the effects of cardiac surgery on cognitive impairment and perioperative hypoperfusion stroke, the role of IABP on alterations of cerebral hemodynamic parameters is of considerable interest.
2 Neuro ICU: Intra-Aortic Balloon Pump (IABP)
In the neuro intensive care unit , the IABP has been used in patients with subarachnoid hemorrhage (SAH) [2, 4, 16] in two distinct clinical situations. The first one is the neurogenic stunned myocardium, that is, a severe condition characterized by reversible left ventricular dysfunction [17]. Neurogenic stunned myocardium following SAH occurs in 20–30% of SAH patients and may result in several complications such as cardiac arrhythmia, pulmonary edema, and prolonged intubation, which can negatively impact morbidity and mortality as well as long-term recovery [17]. Patient management remains basically supportive with case reports acknowledging the utility of contractility vasopressors such as dobutamine and milrinone [17]. Limited data also suggested the utility of IABP in patients who require hemodynamic support when neurogenic stunned myocardium is accompanied by cardiogenic shock [4, 18].
The second clinical situation reported is when patients develop refractory cardiogenic shock despite vasopressor use in cerebral vasospasm after SAH [2, 18]. Cerebral vasospasm is a major cause of morbidity and mortality following aneurysmal SAH and contributes to delayed cerebral ischemia [19]. The combination of induced hypertension, hypervolemia, and hemodilution (triple-H therapy) is often used to improve cerebral perfusion pressure following cerebral vasospasm [20]. Although this approach has gained widespread acceptance over the past 20 years, the efficacy of triple-H therapy in the management of the acute phase of SAH may be questioned [19]. The IABP can improve the hemodynamic status of patients, who would probably die without such therapy and allow the continuing use of triple-H therapy [3].
TDC is a standard screening tool for vasospasm, but the predictive value of mean flow velocity (MFV) is likely inaccurate in the setting of an IABP, as the aforementioned alterations in the arterial waveform are reflected in the TCD velocity waveform (Fig. 61.1). There is just one study that explored this topic; Morris and colleagues reviewed cases of SAH that underwent same-day TDC and angiography [2]. TDC/TCCS waveforms were assessed for MFV, peak systolic velocity (PSV), balloon pump-augmented diastolic velocity, and a novel feature that they called “delta velocity ” (balloon pump-augmented velocity—systolic velocity) [2]. The authors concluded that delta velocity, a novel transcranial Doppler flow velocity feature, may reflect vasospasm in patients with SAH with IABP support. The MFV, usually considered the most accurate TCD/TCCS measure of proximal vasospasm, was not significantly correlated with proximal vasospasm, although it was correlated with distal vasospasm [2]. However, these data are from a single, retrospective observational study. Clearly, interpretation of the waveform in patients with IABP for vasospasm detection requires further investigation.
3 Cerebral Blood Flow : IABP Effects
Although its benefits for improving cardiac function have been well documented, the effects of IABP on the cerebral circulation are still not well understood. Studies investigating the effects of IABP on the cerebral circulation provide conflicting results and have suggested that IABP either decreased, increased, or even transiently reversed cerebral blood flow [21,22,23]. What is clear though is that the use of IABP can change the temporal pattern of CBFV waveforms during the cardiac cycle, leading to characteristic double-peaked waveforms (Figs. 61.2 and 61.3) and the occurrence of transient reversed diastolic (i.e., negative) values of CBFV recorded with TCD [21, 24].
Cheung et al. reported in their study with 19 patients that IABP modified the pattern of CBFV in the middle cerebral artery (MCA) as measured by TCD but did not affect mean CBFV, even at different magnitudes of augmentation or trigger ratios [21]. They also concluded that IABP modified the phasic profile of cerebral blood flow to reflect the arterial pressure waveform (Figs. 61.2 and 61.3), and this pattern was not showing on standby mode.
Notwithstanding some studies reported that the IABP device probably not changes the MFV. Currently, this device uses a square-wave function to control gas flow into the balloon [8], and with TCD, it may be possible to devise nonlinear inflation/deflation sequences for intra-aortic balloon pumps that can maximize forward blood flow in the intracranial circulation [24].
3.1 Transient Reversed Diastolic CBFV
Late diastolic IABP flow reversal in CBFV was first described in 1990 when TCD was used to evaluate CBF in three patients with an IABP [24]. This phenomenon is not uncommon; studies suggested that waveform flow reversal in intracranial vessels may occur in up to 35% of cardiac surgery patients supported by IABP [22].
Under normal conditions, forward CBFV is detected in both systole and diastole with TCD. The reversal of diastolic CBFV implies negative CBF in diastole (Fig. 61.4) and has also been described in other cerebrovascular conditions such as intracranial hypertension, intracranial circulatory arrest, in the first minutes after acute SAH, in metabolically compromised comatose patients, and, in the posterior circulation, the subclavian steal syndrome [24, 25]. However, the clinical significance of this dramatic alteration in the CBF waveform pattern is still unknown and more research on its implications is urgently needed [26].
Reversal of diastolic CBFV has been reported in a few case studies in the literature [27, 28]. The reversal or absence of diastolic flow at late diastole is probably due to diastolic pressure rapid reduction induced by deflation of IABP, so this phenomenon is a direct cause of IABP utilization (Fig. 61.4). These case reports suggest that reversal of diastolic CBFV is iatrogenic and it should be avoided. One possible approach is to optimize the balloon inflation/deflation cycle, by moving deflation to the absolute end of diastole [24, 27]. Although the precise effects of CBFV diastolic reversal on cerebral hemodynamics are still unknown, its departure from normal physiological waveforms is likely to be undesirable and to have a negative effect on CA.
TDC available in ICU, as an easy-to-use, safe, and low-cost bedside tool, is advantageous to identify the reversal of diastolic CBFV in patients with IABP. Furthermore, it could be helpful to assess the hemodynamic response to changes in the balloon deflation timings to minimize the flow reversal phenomenon.
4 IABP: Cerebral Autoregulation
The main reason why IABP might disturb CBF and/or its regulatory mechanisms is due to observed changes in CBF temporal patterns. Chiefly among these regulatory mechanism is cerebral autoregulation (CA) that maintains cerebral perfusion within strict limits despite changes in mean ABP in the range 60–150 mmHg [29].
Assessments of CA are generally classified as being “static” or “dynamic” [30]. Static CA refers to the steady-state relationship between ABP and CBF [30, 31]. Dynamic CA reflects the transient response of CBF, often recorded as CBFV with TCD to rapid changes in ABP [31]. Impairment of CA renders the brain less tolerant to both low and high ABP, with increased risks of significant brain oligemia and hyperemia, respectively [32]. Assessment of CA in critical care patients and those with IABP could be an important bedside tool to avoid these complications [50].
There are numerous methods of quantification and assessment of CA in use at the current time, each with their own inherent assumptions, caveats, and specific analytical models. Importantly, no particular method is currently considered to be the “gold standard” [33].
Hypo- and hyper-perfusion, resulting from disturbances in cerebral autoregulation, are thought to be contributing factors in the neurological complications following cardiac surgery with cardiopulmonary bypass, and the use of IABP could also play a part in the development of these complications [34,35,36].
Hitherto, only two studies evaluated cerebral autoregulation in patients with IABP [37, 38]. These studies used different methods to assess cerebral autoregulation. Caldas et al. (2017) used transfer function analysis and the autoregulation index (ARI) to quantify the efficiency of CA [31, 37]. The second study (Bellapart 2010) was based on the time-delay between fluctuations in CBFV and ABP, estimated using a cross-correlation technique. Both studies found that cerebral autoregulation was intact in patients with IABP [37, 38].
One important corollary of these studies though was demonstrating the feasibility of performing bedside assessments of CA in critically ill patients requiring the use of IABP or different invasive support devices. Several critical care conditions were reported with impairment of cerebral autoregulation, such as sepsis, perioperative of cardiac surgery, ischemic heart disease, or SAH, and these conditions may be requiring the use of IABP [39,40,41,42,43,44]. Patients who have manifested impairment of CA should have close monitoring and management of arterial blood pressure, to prevent ischemia or hyper-perfusion.
5 IABP and TCD/TCCS : Other Miscellaneous Conditions
5.1 Microemboli
Monitoring of the cerebral circulation with TCD can identify microemboli within the MCA during cardiopulmonary bypass procedures [45,46,47]. Similar techniques during the use of left ventricular assist devices may help identify occult cerebral embolization with IABP. Cerebral air embolism is a neurological emergency most commonly iatrogenic in origin [14]. It has been reported following invasive procedures such as cardiac catheterization, central venous catheter insertion, and cardiothoracic surgery. This complication, previously reported in patients with IABP when there is a rupture with gas embolization, is a rare but potentially fatal event [48].
5.2 Brain Death
The classical TCD pattern in brain death consists of three stages: oscillating or biphasic flow, systolic spike flow, and no flow [49]. With increasing intracranial pressure, diastolic flow ceases and systolic peaks become sharper. As cerebral perfusion pressure approaches zero , there is collapse of blood vessels during diastole, and so absent or reversed diastolic flow can be demonstrated.
The IABP can induce alterations in the pattern of CBFV measurements and the reversal of flow in late diastole may appear [24, 27]. Therefore, in a patient with an IABP, who is clinically brain dead, the IABP has to be on standby to allow a proper determination of the actual CBFV. The classic TCD pattern has to be detectable for at least 30 minutes [25] to confirm the diagnosis of brain death.
6 Conclusion
IABP significantly changes CBF temporal patterns in basal cerebral arteries. TCD provides valuable information about cerebral hemodynamics with intra-aortic balloon pumping, given the ability to measure subsecond changes in cerebral hemodynamics.
The IABP is an important resource to support the failing heart, in diverse clinical situations, but the alterations produced in the systemic circulation are transmitted to the brain, resulting in alterations of the CBFV temporal pattern, whose implications still require more detailed investigation. The use of TCD for monitoring patients with IABP, and also performing a number of dedicated assessments, such as dynamic CA or brain death, is recommended.
Further studies are needed in patients with IABP to assess the extent of cerebral hemodynamic effects, particularly regarding the phenomenon of diastolic CBFV reversal.
References
White JM, Ruygrok PN. Intra-aortic balloon counterpulsation in contemporary practice where are we? Heart Lung Circ. 2015;24(4):335–41.
Morris NA, Manning N, Marshall RS, Connolly ES, Claassen J, Agarwal S, et al. Transcranial Doppler waveforms during intra-aortic balloon pump counterpulsation for vasospasm detection after subarachnoid hemorrhage. Neurosurgery. 2018;83(3):416–21.
Taccone FS, Lubicz B, Piagnerelli M, Van Nuffelen M, Vincent J-L, De Backer D. Cardiogenic shock with stunned myocardium during triple-H therapy treated with intra-aortic balloon pump counterpulsation. Neurocrit Care. 2009;10(1):76–82.
Ducruet AF, Albuquerque FC, Crowley RW, Williamson R, Forseth J, McDougall CG. Balloon-pump counterpulsation for management of severe cardiac dysfunction after aneurysmal subarachnoid hemorrhage. World Neurosurg. 2013;80(6):347.
Kantrowitz A. Experimental augmentation of coronary flow by retardation of the arterial pressure pulse. Surgery. 1953;34(4):678–87.
Vignola PA, Swaye PS, Gosselin AJ. Guidelines for effective and safe percutaneous intraaortic balloon pump insertion and removal. Am J Cardiol. 1981;48(4):660–4.
Klopman MA, Chen EP, Sniecinski RM. Positioning an intraaortic balloon pump using intraoperative transesophageal echocardiogram guidance. Anesth Analg. 2011;113(1):40–3.
Webb CAJ, Weyker PD, Flynn BC. Management of Intra-Aortic Balloon Pumps. Semin Cardiothorac Vasc Anesth. 2015;19(2):106–21.
Urschel CW, Eber L, Forrester J, Matloff J, Carpenter R, Sonnenblick E. Alteration of mechanical performance of the ventricle by intraaortic balloon counterpulsation. Am J Cardiol. 1970;25(5):546–51.
Williams DO, Korr KS, Gewirtz H, Most AS. The effect of intraaortic balloon counterpulsation on regional myocardial blood flow and oxygen consumption in the presence of coronary artery stenosis in patients with unstable angina. Circulation. 1982;66(3):593–7.
Kern MJ, Aguirre F, Bach R, Donohue T, Siegel R, Segal J. Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation. 1993;87(2):500–11.
Patel JJ, Kopisyansky C, Boston B, Kuretu ML, McBride R, Cohen M. Prospective evaluation of complications associated with percutaneous intraaortic balloon counterpulsation. Am J Cardiol. 1995;76(16):1205–7.
Beholz S, Braun J, Ansorge K, Wollert HG, Eckel L. Paraplegia caused by aortic dissection after intraaortic balloon pump assist. Ann Thorac Surg. 1998;65(2):603–4.
Cruz-Flores S, Diamond AL, Leira EC. Cerebral air embolism secondary to intra-aortic balloon pump rupture. Neurocrit Care. 2005;2(1):49–50.
Honet JC, Wajszczuk WJ, Rubenfire M, Kantrowitz A, Raikes JA. Neurological abnormalities in the leg(s) after use of intraaortic balloon pump: report of six cases. Arch Phys Med Rehabil. 1975;56(8):346–52.
Al-Mufti F, Morris N, Lahiri S, Roth W, Witsch J, Machado I, et al. Use of intra-aortic- balloon pump counterpulsation in patients with symptomatic vasospasm following subarachnoid Hemorrhage and neurogenic stress cardiomyopathy. J Vasc Interv Neurol. 2016;9(1):28–34.
Kerro A, Woods T, Chang JJ. Neurogenic stunned myocardium in subarachnoid hemorrhage. J Crit Care. 2017;38:27–34.
Lazaridis C, Pradilla G, Nyquist PA, Tamargo RJ. Intra-aortic balloon pump counterpulsation in the setting of subarachnoid hemorrhage, cerebral vasospasm, and neurogenic stress cardiomyopathy. Case report and review of the literature. Neurocrit Care. 2010;13(1):101–8.
Milinis K, Thapar A, O’Neill K, Davies AH. History of aneurysmal spontaneous subarachnoid hemorrhage. Stroke. 2017;48(10):e280–3.
Dumont AS, Dumont RJ, Chow MM, Lin C-L, Calisaneller T, Ley KF, et al. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery. 2003;53(1):123–33; discussion 133–135.
Cheung AT, Levy WJ, Weiss SJ, Barclay DK, Stecker MM. Relationships between cerebral blood flow velocities and arterial pressures during intra-aortic counterpulsation. J Cardiothorac Vasc Anesth. 1998;12(1):51–7.
Schachtrupp A, Wrigge H, Busch T, Buhre W, Weyland A. Influence of intra-aortic balloon pumping on cerebral blood flow pattern in patients after cardiac surgery. Eur J Anaesthesiol. 2005;22(3):165–70.
Pfluecke C, Christoph M, Kolschmann S, Tarnowski D, Forkmann M, Jellinghaus S, et al. Intra-aortic balloon pump (IABP) counterpulsation improves cerebral perfusion in patients with decreased left ventricular function. Perfusion. 2014;29(6):511–6.
Brass LM. Reversed intracranial blood flow in patients with an intra-aortic balloon pump. Stroke. 1990;21(3):484–7.
van der Naalt J, Baker AJ. Influence of the intra-aortic balloon pump on the transcranial Doppler flow pattern in a brain-dead patient. Stroke. 1996;27(1):140–2.
Caldas JR, Panerai RB, Passos R, et al. Is there still a place for transcranial Doppler in patients with IABP? Crit Care. 2020;24:625.
Gao Y-Z, Zhang M. Effect of intra-aortic balloon pump on reversal of diastolic cerebral flow: deflated too early? Neurocrit Care. 2018;29:313–4.
Schutt RC, Bhimiraj A, Estep JD, Guha A, Trachtenberg BH, Garami Z. Deflation timing influences intra-aortic balloon pump-mediated carotid blood flow reversal: a case report. Circ Heart Fail. 2016;9(9):e003474.
Paulson OB, Strandgaard S, Edvinsson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev. 1990;2(2):161–92.
Aaslid R, Lindegaard KF, Sorteberg W, Nornes H. Cerebral autoregulation dynamics in humans. Stroke. 1989;20(1):45–52.
Tiecks FP, Lam AM, Aaslid R, Newell DW. Comparison of static and dynamic cerebral autoregulation measurements. Stroke. 1995;26(6):1014–9.
Panerai RB. Transcranial Doppler for evaluation of cerebral autoregulation. Clin Auton Res. 2009;19(4):197–211.
Tzeng YC, Ainslie PN, Cooke WH, Peebles KC, Willie CK, MacRae BA, et al. Assessment of cerebral autoregulation: the quandary of quantification. Am J Physiol Circ Physiol. 2012;303(6):658.
Scolletta S, Taccone FS, Donadello K. Brain injury after cardiac surgery. Minerva Anestesiol. 2015;81(6):662–77.
Brown CH 4th, Faigle R, Klinker L, Bahouth M, Max L, LaFlam A, et al. The association of brain MRI characteristics and postoperative delirium in cardiac surgery patients. Clin Ther. 2015;37(12):2699.e9.
Koster S, Hensens AG, Schuurmans MJ, van der Palen J. Risk factors of delirium after cardiac surgery: a systematic review. Eur J Cardiovasc Nurs. 2011;10(4):197–204.
Caldas JR, Panerai RB, Bor-Seng-Shu E, Almeida JP, Ferreira GSR, Camara L, et al. Cerebral hemodynamics with intra-aortic balloon pump: business as usual? Physiol Meas. 2017;38(7):1349–61.
Bellapart J, Geng S, Dunster K, Timms D, Barnett AG, Boots R, et al. Intraaortic balloon pump counterpulsation and cerebral autoregulation: an observational study. BMC Anesthesiol. 2010;10:3.
Schramm P, Klein KU, Falkenberg L, Berres M, Closhen D, Werhahn KJ, et al. Impaired cerebrovascular autoregulation in patients with severe sepsis and sepsis-associated delirium. Crit Care. 2012;16(5):181.
Salinet AS, Panerai RB, Robinson TG. The longitudinal evolution of cerebral blood flow regulation after acute ischaemic stroke. Cerebrovasc Dis Extra. 2014;4(2):186–97.
Ma H, Guo ZN, Liu J, Xing Y, Zhao R, Yang Y. Temporal course of dynamic cerebral autoregulation in patients with intracerebral hemorrhage. Stroke. 2016;47(3):674–81.
Caldas JR, Panerai RB, Haunton VJ, Almeida JP, Ferreira GSR, Camara L, et al. Cerebral blood flow autoregulation in ischemic heart failure. Am J Physiol Regul Integr Comp Physiol. 2016;312:108–13.
Budohoski KP, Czosnyka M, Kirkpatrick PJ, Reinhard M, Varsos GV, Kasprowicz M, et al. Bilateral failure of cerebral autoregulation is related to unfavorable outcome after subarachnoid hemorrhage. Neurocrit Care. 2015;22(1):65–73.
Caldas JR, Haunton VJ, Panerai RB, Hajjar LA, Robinson TG. Cerebral autoregulation in cardiopulmonary bypass surgery: a systematic review. Interact Cardiovasc Thorac Surg. 2017;6
Kunt A, Atbas C, Hidiroglu M, Cetin L, Erdogan KE, Kucuker A, et al. Predictors and outcomes of minor cerebrovascular events after cardiac surgery: a multivariable analysis of 1346 patients. J Cardiovasc Surg. 2013;54(4):537–43.
Al-Atassi T, Lam K, Forgie M, Boodhwani M, Rubens F, Hendry P, et al. Cerebral microembolization after bioprosthetic aortic valve replacement comparison of warfarin plus aspirin versus aspirin only. Circulation. 2012;126(11):S239–44.
Barbut D, Yao FSF, Lo YW, Silverman R, Hager DN, Trifiletti RR, et al. Determination of size of aortic emboli and embolic load during coronary artery bypass grafting. Ann Thorac Surg. 1997;63(5):1262–7.
Furman S, Vijaynagar R, Rosenbaum R, McMullen M, Escher DJ. Lethal sequelae of intra-aortic balloon rupture. Surgery. 1971;69(1):121–9.
Ropper AH, Kehne SM, Wechsler L. Transcranial Doppler in brain death. Neurology. 1987;37(11):1733–5.
Caldas JR, Panerai RB, Bor-Seng-Shu E, et al. Intra-aortic balloon pump does not influence cerebral hemodynamics and neurological outcomes in high-risk cardiac patients undergoing cardiac surgery: an analysis of the IABCS trial. Ann Intensive Care. 2019;9(1):130.
Murli K, Zacharowski K. Principles of intra-aortic balloon pump counterpulsation. Contin Educ Anaesth Crit Care Pain. ScienceDirect. 2009;9(1):24–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Algorithm
Algorithm
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Caldas, J., Panerai, R.B. (2022). Intra-Aortic Balloon Pump (IABP) in ICU: Cerebral Hemodynamics Monitoring by Transcranial Doppler (TCD/TCCS). In: Rodríguez, C.N., et al. Neurosonology in Critical Care . Springer, Cham. https://doi.org/10.1007/978-3-030-81419-9_61
Download citation
DOI: https://doi.org/10.1007/978-3-030-81419-9_61
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-81418-2
Online ISBN: 978-3-030-81419-9
eBook Packages: MedicineMedicine (R0)